Dr. Joanna Horobin

Insider Reports History

Location
Morrisville, NC
Signature
/s/ Dr. Joanna Horobin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dr. Joanna Horobin:

Form 4 holding Director

Vyant Bio, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
23,123
Estimated value
$30,846
Report date
17 Jan 2023
Price
$1.33
Ownership
Direct
Form 4 holding Director

Kymera Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
33,195
Estimated value
Report date
07 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Dr. Joanna Horobin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .